Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03073447Not ApplicableCompleted

WAMIF : Young Women Presenting Acute Myocardial Infarction in France

Role: collaborator

NCT01266694Phase 4Completed

Cochicine Treatment for Post- Operative Pericardial Effusion

Role: collaborator

NCT01714752Not ApplicableCompleted

Evaluation of Left Ventricular Filling Pressures During Exercise

Role: collaborator

NCT00484380Not ApplicableCompleted

The Scanner in the Coronary Evaluation

Role: collaborator

NCT01122810Not ApplicableCompleted

Scanner and Transplant Heart Patients Protocol

Role: collaborator

All 5 trials loaded